(28 days)
Not Found
Not Found
No
The summary describes a test stimulation lead, a physical component of a neurostimulation system, with no mention of software, algorithms, or AI/ML capabilities.
Yes
The device is indicated for managing chronic pain, which is a therapeutic purpose. It delivers electrical stimulation to block pain signals.
No
The device is a test stimulation lead used to deliver electrical stimulation for pain management, not to diagnose a condition. It is described as an "aid in the management of chronic, intractable... pain."
No
The device description explicitly states it is a "test stimulation lead with accessories included in the kit," describing it as a "thin wire covered by an insulative coating" with "small metal electrodes." This clearly indicates a physical hardware component, not a software-only device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is an "aid in the management of chronic, intractable, unilateral or bilateral pain associated with" various conditions. This describes a therapeutic or diagnostic procedure performed on the patient's body, not a test performed on a sample taken from the patient's body.
- Device Description: The device is described as a "test stimulation lead" that delivers electrical stimulation to an area where pain signals will be blocked. This is an implantable or externally connected device used for direct interaction with the patient's nervous system.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) or providing information about a patient's health status based on such analysis.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device does not fit that description.
N/A
Intended Use / Indications for Use
The Model 3875 1 x 8 SC Test Stimulation Lead is indicated as an aid in the management of chronic, intractable, unilateral or bilateral pain associated with the following:
- Failed Back Syndrome or Low Back Syndrome or Failed Back;
- Radicular Pain Syndrome or Radiculopathies resulting in pain secondary to Failed Back Syndrome;
- Post Laminectomy Pain;
- Unsuccessful Disk Surgery;
- Degenerative Disk Disease (DDD/ Herniated pain refractory to conservative and surgical interventions;
- Peripheral Causalgia;
- Epidural Fibrosis;
- Arachnoiditis or Lumbar Adhesive Arachnoiditis;
- Complex Regional Pain Syndrome (CRPS) or Reflex Sympathetic Dystrophy (RSD) or Causalgia; and,
- Multiple Back Surgeries
Additional Contraindication: The Medtronic Model 3875 1 x 8 SC Test Stimulation Lead Kit is contraindicated for long-term implantation. The lead MUST BE REMOVED within ten (10) days of implant.
Product codes (comma separated list FDA assigned to the subject device)
GZB
Device Description
The Model 3875 1 x 8 SC is a test stimulation lead with accessories included in the kit. A test stimulation lead is a thin wire covered by an insulative coating, which is intended to be connected to a screening cable and to an external neurostimulator (ENS). The lead has small metal electrodes near its tip through which the ENS delivers electrical stimulation to an area where pain signals will be blocked.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
In Vitro testing on the design of the Model 3875 1 x 8 SC has been previously performed and repeat testing was not deemed necessary to support equivalence to the predicate devices. This is documented for the Model 3875 1 x 8 SC Test. Stimulation Lead in report 07TR.020 and report NDHF1174-90920, which are located in Appendix E and Appendix G respectively, and in the design history file, NDHF1174.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
The predicate devices for the Medtronic Model 3875 1 x 8 SC Test Stimulation Lead are the currently available Model 3873 1 x 8 Test Stimulation Lead and Model 3874 1 x 8 Compact Test Stimulation Lead.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.5880 Implanted spinal cord stimulator for pain relief.
(a)
Identification. An implanted spinal cord stimulator for pain relief is a device that is used to stimulate electrically a patient's spinal cord to relieve severe intractable pain. The stimulator consists of an implanted receiver with electrodes that are placed on the patient's spinal cord and an external transmitter for transmitting the stimulating pulses across the patient's skin to the implanted receiver.(b)
Classification. Class II (performance standards).
0
Appendix A: 510(K) Summary
Submitter
Medtronic, Inc. 710 Medtronic Parkway NE Minneapolis, MN 55432
AUG 16 2006
| Contact: | Paula Cordero, Senior Regulatory Affairs Specialist |
|---|---|
| Telephone: | (763) 505-0238 |
| Fax: | (763) 505-0258 |
| E-Mail: | paula.cordero@medtronic.com |
| Date Prepared: | July 18th, 2006 |
Name of Device
| Trade Name: | Medtronic Model 3875 1 x 8 SC Test Stimulation Lead |
|---|---|
| Common Name: | Neurostimulation Trialing Lead |
| Classification: | Class II |
| Product Code: | GZB |
Predicate Devices
The predicate devices for the Medtronic Model 3875 1 x 8 SC Test Stimulation Lead are the currently available Model 3873 1 x 8 Test Stimulation Lead and Model 3874 1 x 8 Compact Test Stimulation Lead.
Device Description
The Model 3875 1 x 8 SC is a test stimulation lead with accessories included in the kit. A test stimulation lead is a thin wire covered by an insulative coating, which is intended to be connected to a screening cable and to an external neurostimulator (ENS). The lead has small metal electrodes near its tip through which the ENS delivers electrical stimulation to an area where pain signals will be blocked.
Intended Use
The intended use and indications of the modified device, Model 3875 1 x 8 SC Test Stimulation Lead, as described in the labeling, are the same as the intended use and indications for Medtronic's unmodified predicate devices.
The Model 3875 1 x 8 SC Test Stimulation Lead is indicated as an aid in the management of chronic, intractable, unilateral or bilateral pain associated with the following:
- Failed Back Syndrome or Low Back Syndrome or Failed Back;
Image /page/0/Picture/18 description: The image contains the Medtronic logo and the word "Confidential" below it. The Medtronic logo is a stylized image of a person reaching for the sky. The word "Medtronic" is in a bold, sans-serif font. The word "Confidential" is in a smaller, sans-serif font.
1
- Radicular Pain Syndrome or Radiculopathies resulting in pain secondary to . Failed Back Syndrome:
- . Post Laminectomy Pain:
- . Unsuccessful Disk Surgery:
- Degenerative Disk Disease (DDD/ Herniated pain refractory to conservative . and surgical interventions;
- . Peripheral Causalgia;
- . Epidural Fibrosis;
- Arachnoiditis or Lumbar Adhesive Arachnoiditis; ●
- Complex Regional Pain Syndrome (CRPS) or Reflex Sympathetic Dystrophy . (RSD) or Causalgia; and,
- . Multiple Back Surgeries
Additional Contraindication: The Medtronic Model 3875 1 x 8 SC Test Stimulation Lead Kit is contraindicated for long-term implantation. The lead MUST BE REMOVED within ten (10) days of implant.
Summary of Studies
In Vitro testing on the design of the Model 3875 1 x 8 SC has been previously performed and repeat testing was not deemed necessary to support equivalence to the predicate devices. This is documented for the Model 3875 1 x 8 SC Test. Stimulation Lead in report 07TR.020 and report NDHF1174-90920, which are located in Appendix E and Appendix G respectively, and in the design history file, NDHF1174.
Sterilization
The Medtronic Model 3875 1 x 8 SC Test Stimulation Lead Kit is labeled STERILE. The Model 3875 1 x 8 SC Test Stimulation Lead Kits will be sterilized using the same 100% Ethylene Oxide (EtO) sterilization wrocess as the predicate devices.
Biocompatibility
All materials used in the Model 3875 1 x 8 SC Test Stimulation Lead Kit are identical to the materials used in the predicate devices, Models 3873 and 3874 Test Stimulation Leads, and additional biocompatibility testing was not 50% of necessary for the Model 3875 1 x 8 SC Test Stimulation Lead and accessory components. All device materials / components were assessed for biocompatibility consistent with ISO- 10993, "Biological Evaluation of Medical Devices Part 1: Evaluation and Testing" for the predicate devices. All materials were found to be biocompatible and in compliance to ISO 10993-1
Image /page/1/Picture/18 description: The image contains the Medtronic logo, which includes a stylized human figure with outstretched arms. Next to the logo, the word "Medtronic" is written in bold, sans-serif font. Below the company name, the word "Confidential" is written in a smaller, regular font.
2
Conclusion
·
Through data and information presented, as well as similarity to legally marketed devices, Medtronic, Inc. considers the Model 3875 1 x 8 SC Test Stimulation Lead Kit to be substantially equivalent to the legally marketed predicate devices.
Image /page/2/Picture/4 description: The image shows the Medtronic logo with the word "Confidential" underneath. The Medtronic logo consists of a stylized image of a person running with a baton, followed by the word "Medtronic" in bold, sans-serif font. The word "Confidential" is written in a smaller, sans-serif font.
3
Image /page/3/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS) of the United States. The seal features the department's name encircling a symbol. The symbol consists of four stylized human figures connected at the base, representing the department's mission to protect the health of all Americans and provide essential human services.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 1 6 2006
Ms. Paula Cordero Senior Regulatory Affairs Specialist Medtronic, Inc 710 Medtronic Parkway Minneapolis, Minnesota 55604
Re: K062041
Trade/Device Name: Medtronic® 3875 1 × 8 SC Test Stimulation Lead Regulation Number: 21 CFR 882.5880 Regulation Name: Implanted spinal cord stimulator for pain relief Regulatory Class: Class II Product Code: GZB Dated: July 18, 2006 Received: July 19, 2006
Dear Ms. Cordero
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
4
Page 2 -- Ms. Paula Cordero
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120 . Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Mark A. Milburn
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use ব
510(k) Number (if known): K_06204 |
Device Name: Medtronic® Model 3875 1 x 8 SC Test Stimulation Lead
Indications For Use: The Model 3875 1 x 8 SC Test Stimulation Lead is indicated as an aid in the management of chronic, intractable, unilateral or bilateral pain associated with the following:
- Failed Back Syndrome or Low Back Syndrome or Failed Back; .
- Radicular Pain Syndrome or Radiculopathies resulting in pain secondary to Failed . Back Syndrome;
- . Post Laminectomy Pain;
- ◆ Unsuccessful Disk Surgery;
- . Degenerative Disk Disease (DDD/ Herniated pain refractory to conservative and surgical interventions;
- . Peripheral Causalgia;
- . Epidural Fibrosis;
- Arachnoiditis or Lumbar Adhesive Arachnoiditis; ◆
- Complex Regional Pain Syndrome (CRPS) or Reflex Sympathetic Dystrophy (RSD) . or Causalgia; and,
- Multiple Back Surgeries .
Additional Contraindication: The Medtronic Model 3875 1 x 8 SC Test Stimulation Lead is contraindicated for long-term implantation. The lead MUST BE REMOVED within ten (10) days of implant.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of General. Restorative
Page 1 of 1
Neurological Devices
$\qquad K0(L_{0})(r)$
Confidential
July 2006